Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells

References

• Fortini P, Dogliotti E. Base damage and single-strand break repair: mechanisms and functional significance of shortand long-patch repair subpathways. DNA Repair (Amst) 2007; 6:398 - 409; http://dx.doi.org/10.1016/j.dnarep.2006.10.008; PMID: 17129767
   PubMed Web of Science ®Google Scholar
• Caldecott KW. Mammalian single-strand break repair: mechanisms and links with chromatin. DNA Repair (Amst) 2007; 6:443 - 53; http://dx.doi.org/10.1016/j.dnarep.2006.10.006; PMID: 17118715
   PubMed Web of Science ®Google Scholar
• Wyman C, Kanaar R. Homologous recombination: down to the wire. Curr Biol 2004; 14:R629 - 31; http://dx.doi.org/10.1016/j.cub.2004.07.049; PMID: 15296782
   PubMed Web of Science ®Google Scholar
• Hefferin ML, Tomkinson AE. Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst) 2005; 4:639 - 48; http://dx.doi.org/10.1016/j.dnarep.2004.12.005; PMID: 15907771
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 2005; 280:31182 - 9; http://dx.doi.org/10.1074/jbc.M506591200; PMID: 16000298
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay D, Mandal M, Adam L, Mendelsohn J, Kumar R. Physical interaction between epidermal growth factor receptor and DNAdependent protein kinase in mammalian cells. J Biol Chem 1998; 273:1568 - 73; http://dx.doi.org/10.1074/jbc.273.3.1568; PMID: 9430697
   PubMed Web of Science ®Google Scholar
• Burma S, Chen DJ. Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) 2004; 3:909 - 18; http://dx.doi.org/10.1016/j.dnarep.2004.03.021; PMID: 15279776
   PubMed Web of Science ®Google Scholar
• Burma S, Chen BP, Chen DJ. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 2006; 5:1042 - 8; http://dx.doi.org/10.1016/j.dnarep.2006.05.026; PMID: 16822724
   PubMed Web of Science ®Google Scholar
• Balaban N, Moni J, Shannon M, Dang L, Murphy E, Goldkorn T. The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta 1996; 1314:147 - 56; http://dx.doi.org/10.1016/S0167-4889(96)00068-7; PMID: 8972728
   PubMed Web of Science ®Google Scholar
• Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002; 62:7350 - 6; PMID: 12499279
   PubMed Web of Science ®Google Scholar
• Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010; 12:675 - 84; PMID: 20824044
   PubMed Web of Science ®Google Scholar
• Nyati MK, Morgan MA, Feng FY, Lawrence TS. Integration of EGFR inhibitors with radiochemotherapy. Nat Rev Cancer 2006; 6:876 - 85; http://dx.doi.org/10.1038/nrc1953; PMID: 17036041
   PubMed Web of Science ®Google Scholar
• Pryor DI, Porceddu SV, Burmeister BH, Guminski A, Thomson DB, Shepherdson K, et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 2009; 90:172 - 6; http://dx.doi.org/10.1016/j.radonc.2008.09.018; PMID: 18976827
   PubMed Web of Science ®Google Scholar
• Crombet T, Osorio M, Cruz T, Roca C, del Castillo R, Mon R, et al. Use of the humanized anti-epidermal growth factor receptor monoclonal antibody nimotuzumab in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients. J Clin Oncol 2004; 22:1646 - 54; http://dx.doi.org/10.1200/JCO.2004.03.089; PMID: 15117987
   PubMed Web of Science ®Google Scholar
• Akashi Y, Okamoto I, Iwasa T, Yoshida T, Suzuki M, Hatashita E, et al. Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status. Br J Cancer 2008; 98:749 - 55; http://dx.doi.org/10.1038/sj.bjc.6604222; PMID: 18253126
   PubMed Web of Science ®Google Scholar
• Allan DGP. Nimotuzumab: Evidence of clinical benefit without rash. Oncologist 2005; 10:760 - 1; http://dx.doi.org/10.1634/theoncologist.10-9-760; PMID: 16249358
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Rodemann H-P. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol 2005; 76:157 - 61; http://dx.doi.org/10.1016/j.radonc.2005.06.022; PMID: 16024112
   PubMed Web of Science ®Google Scholar
• Garrido G, Tikhomirov IA, Rabasa A, Yang E, Gracia E, Iznaga N, et al. Bivalent binding by intermediate affinity of nimotuzumab A contribution to explain antibody clinical profile. Cancer Biol Ther 2011; 11:1 - 3; http://dx.doi.org/10.4161/cbt.11.4.14097; PMID: 21189451
   PubMed Web of Science ®Google Scholar
• Puig P, Barquinero JF. An application of compound Poisson modeling to biological dosimetry. Proc R Soc A 2010; doi:10.1098/rspa.2010.0384.
   Google Scholar
• Deckbar D, Birraux J, Krempler A, Tchouandong L, Beucher A, Walker S, et al. Chromosome breakage after G2 checkpoint release. J Cell Biol 2007; 176:749 - 55; http://dx.doi.org/10.1083/jcb.200612047; PMID: 17353355
   PubMed Web of Science ®Google Scholar
• Löbrich M, Jeggo PA. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Natl Rev 2007; 7:861 - 9; http://dx.doi.org/10.1038/nrc2248; PMID: 17943134
   PubMedGoogle Scholar
• Redon CE, Nakamura AJ, Zhang Y-W, Ji J, Bonner WM, Kinders RJ, et al. Histone γH2AX and Poly (ADP-Ribose) as Clinical Pharmacodynamic Biomarkers. Clin Cancer Res 2010; 16:4532 - 42; http://dx.doi.org/10.1158/1078-0432.CCR-10-0523; PMID: 20823146
   PubMed Web of Science ®Google Scholar
• Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. γH2AX and cancer. Natl Rev 2008; 8:957 - 67; http://dx.doi.org/10.1038/nrc2523
   Google Scholar
• Banath JP, Peggy L. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res 2003; 63:4347 - 50
   PubMed Web of Science ®Google Scholar
• Massimino M, Bode U, Biassoni V, Fleischhack G. Nimotuzumab for pediatric diffuse intrinsic pontine gliomas. Expert Opin Biol Ther 2011; 11:247 - 56; PMID: 21171927
   PubMed Web of Science ®Google Scholar
• Crombet T, Torres L, Neninger E, Catala´ M, Solano M, Perera A, et al. Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody nimotuzumab, in patients with advanced epithelial-derived cancer. J Immunother 2003; 26:139 - 48; http://dx.doi.org/10.1097/00002371-200303000-00006; PMID: 12616105
   PubMed Web of Science ®Google Scholar
• Fracasso P, Burris H, Arquette M, Govindan R, Gao F, Wright L, et al. A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: Pharmacokinetic and pharmacodynamic rationale for dosing. Clin Cancer Res 2007; 13:986 - 93; http://dx.doi.org/10.1158/1078-0432.CCR-06-1542; PMID: 17289894
   PubMed Web of Science ®Google Scholar
• Thomas P, Harvey S, Gruner T, Fenech M. The buccal cytome and micronucleus frequency is substantially altered in Down’s syndrome and normal ageing compared to young healthy controls. Mutat Res 2008; 638:37 - 47; http://dx.doi.org/10.1016/j.mrfmmm.2007.08.012; PMID: 17920640
   PubMed Web of Science ®Google Scholar
• González JE, Roch-Lefèvre SH, Mandina T, García O, Roy L. Induction of γ-H2AX foci in human exfoliated buccal cells after in vitro exposure to ionizing radiation. Int J Radiat Biol 2010; 86:752 - 9; http://dx.doi.org/10.3109/09553002.2010.484476; PMID: 20597838
   PubMed Web of Science ®Google Scholar